XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq’s Minimum Stockholders’ Equity Listing Requirements

RAANANA, Israel, December 6, 2017 /PRNewswire/ —
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTLB.TA) (“XTL” or the “Company”), a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases, today announced that it has received notification from the…